Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the ...

Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE® (setmelanotide) for Patients with Acquired Hypothalamic Obesity ...

European Commission decision anticipated in second quarter of 2026 -- BOSTON, March 26, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutica ...

First and only FDA-approved therapy for the treatment of acquired hypothalamic obesity, a rare disease characterized by accelerated and sustained weight gain caused by hypothalamic injury or dysfuncti ...

Model selection, infrastructure sizing, vertical fine-tuning and MCP server integration. All explained without the fluff. Why Run AI on Your Own Infrastructure? Let’s be honest: over the past two ...

Don’t know the difference between the ground launch sequencer and the ICPS for the Artemis II mission? Here’s everything you need to know to sound like an astronaut.

Last week was a busy one in Frankfort. Here's a quick look at notable bills that have moved on to Gov. Andy Beshear's desk ...

LEO Pharma A/S, a global leader in medical dermatology, today announced the presentation of new post-hoc analyses of 12‑month real‑world data from the TRACE study of tralokinumab, at the 2026 American ...

"Common Injection Molding Design Mistakes and Optimization Guide" was not just breaking news within the First Mold, but a major announcement. The company officially announced this publication as a ...

Fagron Sterile Services (FSS) today announced a major milestone in strengthening the nation's supply of critical injectable ...

The former Ohio State standout is one of many wide receivers in the 2026 NFL Draft. He'd fit best with these five NFL teams.